Abstract
Over the course of the CoVID-19 pandemic, we utilized widely-available real-time data to create models for predicting its spread, and to estimate the time evolution for each of the USA CoVID-19 waves. Our recent medrxiv.org preprint (10.1101_2021.08.16.21262150) examined the USA Summer 2021 resurgence, from ∼6/7/2021 up through ∼8/15/2021 (Stage 1). Our preprint covering this period showed that CoVID-19 could infect virtually all susceptible non-vaccinated persons, who were practicing minimal Social Distancing and NO Mask-Wearing.
The most recent USA Summer 2021 resurgence data, from ∼8/13/2021 up through 10/7/2021 (Stage 2), shows a significant “flattening of the curve”. Since no new government mandates were involved, our interpretation is that some vaccine-hesitant people have now elected to become vaccinated. The Social Distancing parameter in our model showed a ∼6.67X increase between Stage 1 and Stage 2, indicating that this parameter also can serve as an indicator of vaccination rates. The other parameter in our model, which is associated with Mask-Wearing, increased from zero to a finite but relatively small value. Using the 10/7/2021 USA CoVID-19 overall mortality rate of ∼1.60942 % gives these updated predictions for the total number of USA CoVID-19 cases and deaths:
NTOTAL(3/21/2022) ≈ 52, 188, 000 ; NDeaths(3/21/2022) ≈ 839, 900, NTOTAL(3/21/2024) ≈ [52, 787, 000 ; NDeaths(3/21/2024) ≈ 849, 600, assuming no new 2021 Winter Resurgence occurs (with 3 Figures).
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data produced in the present work are contained in the manuscript.
